
Health Care
Viewpoints
Filter by:
CMS Re-Opens Open Payments System
August 18, 2014 | Blog
As my colleague Brian Dunphy previously reported, CMS temporarily closed the Open Payments system earlier this month. Open Payments is the online system through which pharmaceutical and device manufacturers covered by the Sunshine Act report payments and transfers of value made to physicians and teaching hospitals.
Read more
Acute Care Hospitals Settle FCA Lawsuits for $98 Million
August 18, 2014 | Blog | By Brian Dunphy
Community Health Systems, Inc. (CHS) and Community Health Systems Professional Services Corporation, together a national owner and operator of acute care hospitals, and 119 of their hospitals, agreed to pay $98 million to settle seven False Claims Act (FCA) lawsuits filed by qui tam relators around the country.
Read more
Federal Court Rejects Relator's Swapping Allegations in False Claims Act Case
August 15, 2014 | Blog | By Samantha Kingsbury, Karen Lovitch
This week a federal district court in Ohio ruled in favor of Mobilex USA (Mobilex), the country's largest mobile medical imaging company, on a motion for summary judgment in a False Claims Act (FCA) suit filed by a former employee, Kevin P. McDonough.
Read more
OIG Approves Manufacturer’s Direct-to-Patient Discount Sales Program
August 13, 2014 | Blog | By Theresa Carnegie
The Office of Inspector General (“OIG”) recently posted an Advisory Opinion approving a pharmaceutical manufacturer’s direct-to-patient product sales program.
Read more
ML Strategies Posts Weekly Health Care Update on August 11, 2014
August 13, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Update. This publication provides timely information on implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and federal and state health regulatory developments.
Read more
CMS Temporarily Closes the Open Payments System
August 12, 2014 | Blog | By Brian Dunphy
Open Payments is the website through which pharmaceutical and medical device manufacturers (“Manufacturers”) report payments and transfers of value to physicians and teaching hospitals, as required by the Sunshine Act.
Read more
ML Strategies Posts Weekly Health Care Update on July 28, 2014
August 1, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Update. This publication provides timely information on implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and federal and state health regulatory developments.
Read more
Keep the Benefit of the Bargain - Reps and Warranties Survival in Healthcare Deals
July 28, 2014 | Blog
In recent healthcare mergers and acquisitions, we have seen the parties increasingly focus on the survival length of the representations and warranties in the purchase agreements.
Read more
Charting the Future of Premium Subsidies under the Affordable Care Act: Halbig v. Burwell and King v. Burwell
July 24, 2014 | Blog | By Roy Albert
On July 22nd, 2014, two federal appellate courts issued conflicting decisions, within hours of each other, regarding the IRS final rule published on May 23, 2012 (the “IRS Rule”), intended to implement the exchange-related tax credit provisions of the Affordable Care Act (“ACA” or the “Act”).
Read more
ML Strategies Posts Weekly Health Care Update on July 21, 2014
July 22, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Update. This publication provides timely information on implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and federal and state health regulatory developments.
Read more
New Massachusetts Law Targets Self-Referrals of Clinical Laboratory Services
July 18, 2014 | Blog | By Karen Lovitch, Samantha Kingsbury
The Fiscal Year 2015 budget for the Commonwealth of Massachusetts, which was signed into law earlier in the week, included a broad prohibition on clinical laboratory self-referrals.
Read more
ML Strategies Posts Weekly Health Care Update on July 14, 2014
July 15, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Update. This publication provides timely information on implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and federal and state health regulatory developments.
Read more
Corporate Practice of Medicine: An Old Doctrine Breathing New Life
July 15, 2014 | Blog | By Theresa Carnegie
Many states prohibit or limit the corporate practice of medicine (CPOM), either through statute or common law. These states generally bar a business corporation from practicing medicine or employing a physician to provide professional medical services.
Read more
CMS Proposes Changes to Sunshine Act Reporting
July 9, 2014 | Blog
Drug and device manufacturers breathing a sigh of relief after completing their 2013 data submissions under the Physician Payment Sunshine Act (the “Sunshine Act’) must now contend with four proposed changes to the Sunshine Act regulations.
Read more
New York Enacts Out-Of-Network Transparency and Coverage Reform
July 8, 2014 | Blog | By Theresa Carnegie
Last month, a woman sued a health plan, claiming that she was intentionally misled about which physicians were participating providers in the company’s online health insurance exchange established under the Affordable Care Act.
Read more
New Connecticut Pharmacy Rewards Disclosure Bill Took Effect July 1
July 2, 2014 | Blog
On June 12th, Connecticut governor Dannel P. Malloy signed into law "An Act Concerning Pharmacy Rewards Programs And Protected Health Information". The law went into effect July 1st, and applies to pharmacy retailers in the state of Connecticut.
Read more
ML Strategies Posts Weekly Health Care Update on June 30, 2014
July 1, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Update. This publication provides timely information on implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and federal and state health regulatory developments.
Read more
Supreme Court: Closely-Held Corporations Are Protected by the Religious Freedom Restoration Act - Who Will Foot the Bill?
July 1, 2014 | Blog | By Theresa Carnegie
Yesterday morning, the U.S. Supreme Court announced its decision in the much anticipated Burwell v. Hobby Lobby case, holding that closely-held corporations are protected by the Religious Freedom Restoration Act of 1993 (“RFRA”), and therefore cannot be required to pay for employee health plans that cover contraceptives if the corporation’s owners have religious objections.
Read more
OCR Confirms that Medical Records Should Not be Left in the Driveway
June 25, 2014 | Blog | By Theresa Carnegie
The most recent Office for Civil Rights (OCR) HIPAA enforcement action serves as an important reminder to health care providers of the security risks associated with a mishandled medical records custody transfer and the risks of leaving paper records in the driveway.
Read more
ML Strategies Posts Weekly Health Care Update on June 23, 2014
June 25, 2014 | Blog | By Theresa Carnegie
ML Strategies has posted its weekly Health Care Update. This publication provides timely information on implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and federal and state health regulatory developments.
Read more
Explore Other Viewpoints:
- Data Centers & Digital Infrastructure
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- DEI Legal Developments
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- EnforceMintz
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Sustainable Energy & Infrastructure
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Unified Patent Court (UPC)
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology